Cargando…
TP63-Mediated Enhancer Reprogramming Drives the Squamous Subtype of Pancreatic Ductal Adenocarcinoma
The aberrant expression of squamous lineage markers in pancreatic ductal adenocarcinoma (PDA) has been correlated with poor clinical outcomes. However, the functional role of this putative transdifferentiation event in PDA pathogenesis remains unclear. Here, we show that expression of the transcript...
Autores principales: | Somerville, Tim D.D., Xu, Yali, Miyabayashi, Koji, Tiriac, Hervé, Cleary, Cristian R., Maia-Silva, Diogo, Milazzo, Joseph P., Tuveson, David A., Vakoc, Christopher R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6296757/ https://www.ncbi.nlm.nih.gov/pubmed/30428345 http://dx.doi.org/10.1016/j.celrep.2018.10.051 |
Ejemplares similares
-
p73 activates transcriptional signatures of basal lineage identity and ciliogenesis in pancreatic ductal adenocarcinoma
por: Hur, Stella K., et al.
Publicado: (2023) -
Squamous trans-differentiation of pancreatic cancer cells promotes stromal inflammation
por: Somerville, Tim DD, et al.
Publicado: (2020) -
Marker-based CRISPR screening reveals a MED12-p63 interaction that activates basal identity in pancreatic ductal adenocarcinoma
por: Maia-Silva, Diogo, et al.
Publicado: (2023) -
TP63 links chromatin remodeling and enhancer reprogramming to epidermal differentiation and squamous cell carcinoma development
por: Yi, Mei, et al.
Publicado: (2020) -
TP63 Is Significantly Upregulated in Diabetic Kidney
por: Liang, Sitai, et al.
Publicado: (2021)